Evidence map›Paper›PMID 39566039›Full record

ArticleJournal of the American Chemical Society2024

Functionalized Graphene via a One-Pot Reaction Enabling Exact Pore Sizes, Modifiable Pore Functionalization, and Precision Doping.

Kira Coe-Sessions, Alathea E Davies, Bhausaheb Dhokale, Michael J Wenzel, Masoumeh Mahmoudi Gahrouei, Nikiphoros Vlastos, Jordan Klaassen, Bruce A Parkinson, Laura de Sousa Oliveira, John O Hoberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kira Coe-SessionsDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
Alathea E DaviesDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
Bhausaheb DhokaleDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.ORCID 0000-0001-7520-4727
Michael J WenzelDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
Masoumeh Mahmoudi GahroueiDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
Nikiphoros VlastosDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
Jordan KlaassenDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
Bruce A ParkinsonDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.ORCID 0000-0002-8950-1922
Laura de Sousa OliveiraDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.
John O HobergDepartment of Chemistry, University of Wyoming, Laramie, Wyoming 82071, United States.ORCID 0000-0003-3833-8122

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functionalizing graphene with exact pore size, specific functional groups, and precision doping poses many significant challenges. Current methods lack precision and produce random pore sizes, sites of attachment, and amounts of dopant, leading to compromised structural integrity and affecting graphene's applications. In this work, we report a strategy for the synthesis of functionalized graphitic materials with modifiable nanometer-sized pores via a Pictet-Spengler polymerization reaction. This one-pot, four-step synthesis uses concepts based on covalent organic frameworks (COFs) synthesis to produce crystalline two-dimensional materials that were confirmed by PXRD, TEM measurements, and DFT studies. These new materials are structurally analogous to doped graphene and graphene oxide (GO) but, unlike GO, maintain their semiconductive properties when fully functionalized.

Identifiers

PMID39566039
PMCPMC11622224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.